Response to comment on "International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists"

Pharmacotherapy. 2024 Feb;44(2):208-209. doi: 10.1002/phar.2907.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Infective Agents*
  • Communicable Diseases*
  • Consensus
  • Critical Care
  • Cystic Fibrosis* / drug therapy
  • Humans
  • Pharmacists
  • Pharmacy*
  • United States
  • beta-Lactams

Substances

  • beta-Lactams
  • Anti-Infective Agents